nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—AOX1—Methotrexate—muscle cancer	0.0589	0.802	CbGbCtD
Zonisamide—AOX1—Effects of Nitric Oxide—MB—muscle cancer	0.0332	0.127	CbGpPWpGaD
Zonisamide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYF5—muscle cancer	0.00719	0.0275	CbGpPWpGaD
Zonisamide—SCN2B—head—muscle cancer	0.00668	0.023	CbGeAlD
Zonisamide—SCN3B—tendon—muscle cancer	0.00651	0.0224	CbGeAlD
Zonisamide—SCN4B—cardiac atrium—muscle cancer	0.00635	0.0218	CbGeAlD
Zonisamide—SCN3B—Direct p53 effectors—PMS2—muscle cancer	0.00606	0.0232	CbGpPWpGaD
Zonisamide—SCN1B—head—muscle cancer	0.00605	0.0208	CbGeAlD
Zonisamide—SCN3B—vagina—muscle cancer	0.00604	0.0208	CbGeAlD
Zonisamide—SCN1B—testis—muscle cancer	0.00584	0.0201	CbGeAlD
Zonisamide—CA10—head—muscle cancer	0.0058	0.0199	CbGeAlD
Zonisamide—CYP3A4—Vincristine—muscle cancer	0.00574	0.0781	CbGbCtD
Zonisamide—CA8—head—muscle cancer	0.00568	0.0195	CbGeAlD
Zonisamide—CA13—tendon—muscle cancer	0.00567	0.0195	CbGeAlD
Zonisamide—CA1—C-MYB transcription factor network—MYF6—muscle cancer	0.00564	0.0215	CbGpPWpGaD
Zonisamide—SCN3B—Direct p53 effectors—TP73—muscle cancer	0.00564	0.0215	CbGpPWpGaD
Zonisamide—CA10—testis—muscle cancer	0.0056	0.0193	CbGeAlD
Zonisamide—SCN3B—head—muscle cancer	0.00558	0.0192	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—TP73—muscle cancer	0.00556	0.0213	CbGpPWpGaD
Zonisamide—SCN4B—tendon—muscle cancer	0.00553	0.019	CbGeAlD
Zonisamide—CA8—testis—muscle cancer	0.00549	0.0189	CbGeAlD
Zonisamide—CA11—cardiac atrium—muscle cancer	0.00547	0.0188	CbGeAlD
Zonisamide—SCN3B—testis—muscle cancer	0.00539	0.0185	CbGeAlD
Zonisamide—CA13—vagina—muscle cancer	0.00527	0.0181	CbGeAlD
Zonisamide—CYP3A4—Etoposide—muscle cancer	0.00526	0.0716	CbGbCtD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—TP73—muscle cancer	0.00517	0.0198	CbGpPWpGaD
Zonisamide—SCN4B—vagina—muscle cancer	0.00514	0.0177	CbGeAlD
Zonisamide—SCN2B—Developmental Biology—MYF5—muscle cancer	0.00495	0.0189	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—MYF6—muscle cancer	0.00495	0.0189	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—MYF5—muscle cancer	0.00495	0.0189	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—MYF6—muscle cancer	0.00495	0.0189	CbGpPWpGaD
Zonisamide—CA13—head—muscle cancer	0.00486	0.0167	CbGeAlD
Zonisamide—SCN3B—Direct p53 effectors—TP63—muscle cancer	0.00485	0.0185	CbGpPWpGaD
Zonisamide—CA11—tendon—muscle cancer	0.00476	0.0164	CbGeAlD
Zonisamide—SCN4B—head—muscle cancer	0.00474	0.0163	CbGeAlD
Zonisamide—CA13—testis—muscle cancer	0.0047	0.0162	CbGeAlD
Zonisamide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—muscle cancer	0.00463	0.0177	CbGpPWpGaD
Zonisamide—CA11—bone marrow—muscle cancer	0.00461	0.0159	CbGeAlD
Zonisamide—SCN4B—testis—muscle cancer	0.00458	0.0158	CbGeAlD
Zonisamide—SCN4B—Developmental Biology—MYF6—muscle cancer	0.00453	0.0173	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—MYF5—muscle cancer	0.00453	0.0173	CbGpPWpGaD
Zonisamide—CACNA1I—testis—muscle cancer	0.00448	0.0154	CbGeAlD
Zonisamide—CA11—vagina—muscle cancer	0.00442	0.0152	CbGeAlD
Zonisamide—SCN3B—Developmental Biology—MYF6—muscle cancer	0.00421	0.0161	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—MYF5—muscle cancer	0.00421	0.0161	CbGpPWpGaD
Zonisamide—CA11—head—muscle cancer	0.00408	0.014	CbGeAlD
Zonisamide—CA7—renal system—muscle cancer	0.00406	0.014	CbGeAlD
Zonisamide—CA11—testis—muscle cancer	0.00394	0.0136	CbGeAlD
Zonisamide—CYP3A4—Doxorubicin—muscle cancer	0.00359	0.0488	CbGbCtD
Zonisamide—CA3—cardiac atrium—muscle cancer	0.00334	0.0115	CbGeAlD
Zonisamide—SCN11A—head—muscle cancer	0.00333	0.0114	CbGeAlD
Zonisamide—CACNA1H—smooth muscle tissue—muscle cancer	0.00323	0.0111	CbGeAlD
Zonisamide—SCN2B—Developmental Biology—MYOG—muscle cancer	0.00319	0.0122	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—MYOG—muscle cancer	0.00319	0.0122	CbGpPWpGaD
Zonisamide—CACNA1G—head—muscle cancer	0.00318	0.0109	CbGeAlD
Zonisamide—CA14—cardiac atrium—muscle cancer	0.00303	0.0104	CbGeAlD
Zonisamide—SCN4A—renal system—muscle cancer	0.00296	0.0102	CbGeAlD
Zonisamide—SCN4B—Developmental Biology—MYOG—muscle cancer	0.00292	0.0112	CbGpPWpGaD
Zonisamide—CA3—tendon—muscle cancer	0.00291	0.01	CbGeAlD
Zonisamide—CA3—bone marrow—muscle cancer	0.00282	0.00969	CbGeAlD
Zonisamide—CA9—tendon—muscle cancer	0.00278	0.00957	CbGeAlD
Zonisamide—SCN3B—Developmental Biology—MYOG—muscle cancer	0.00271	0.0104	CbGpPWpGaD
Zonisamide—CA3—vagina—muscle cancer	0.0027	0.00928	CbGeAlD
Zonisamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—muscle cancer	0.00269	0.0103	CbGpPWpGaD
Zonisamide—CA14—tendon—muscle cancer	0.00264	0.00908	CbGeAlD
Zonisamide—CA12—renal system—muscle cancer	0.00264	0.00907	CbGeAlD
Zonisamide—CA6—head—muscle cancer	0.00263	0.00905	CbGeAlD
Zonisamide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—muscle cancer	0.00262	0.01	CbGpPWpGaD
Zonisamide—SCN9A—tendon—muscle cancer	0.00259	0.0089	CbGeAlD
Zonisamide—CA3—head—muscle cancer	0.00249	0.00857	CbGeAlD
Zonisamide—CA3—testis—muscle cancer	0.00241	0.00828	CbGeAlD
Zonisamide—SCN4A—tendon—muscle cancer	0.00231	0.00794	CbGeAlD
Zonisamide—CA9—testis—muscle cancer	0.0023	0.00793	CbGeAlD
Zonisamide—SCN3A—renal system—muscle cancer	0.0023	0.00791	CbGeAlD
Zonisamide—CACNA1I—Developmental Biology—MYF5—muscle cancer	0.00227	0.00869	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MYF6—muscle cancer	0.00227	0.00869	CbGpPWpGaD
Zonisamide—CA1—C-MYB transcription factor network—MYOD1—muscle cancer	0.00224	0.00858	CbGpPWpGaD
Zonisamide—CA1—C-MYB transcription factor network—CD34—muscle cancer	0.00224	0.00858	CbGpPWpGaD
Zonisamide—MAOB—embryo—muscle cancer	0.00224	0.0077	CbGeAlD
Zonisamide—AOX1—renal system—muscle cancer	0.0022	0.00757	CbGeAlD
Zonisamide—SCN11A—Developmental Biology—MYF6—muscle cancer	0.00216	0.00824	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—MYF5—muscle cancer	0.00216	0.00824	CbGpPWpGaD
Zonisamide—SCN9A—testis—muscle cancer	0.00214	0.00737	CbGeAlD
Zonisamide—CA5B—cardiac atrium—muscle cancer	0.00212	0.00729	CbGeAlD
Zonisamide—CA1—renal system—muscle cancer	0.00209	0.00719	CbGeAlD
Zonisamide—SCN5A—cardiac atrium—muscle cancer	0.00205	0.00706	CbGeAlD
Zonisamide—CACNA1H—testis—muscle cancer	0.00201	0.0069	CbGeAlD
Zonisamide—SCN4A—head—muscle cancer	0.00198	0.0068	CbGeAlD
Zonisamide—SCN1B—Developmental Biology—MYOD1—muscle cancer	0.00197	0.00753	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—MYOD1—muscle cancer	0.00197	0.00753	CbGpPWpGaD
Zonisamide—AOX1—cardiac atrium—muscle cancer	0.00197	0.00678	CbGeAlD
Zonisamide—MAOA—embryo—muscle cancer	0.00191	0.00657	CbGeAlD
Zonisamide—SCN4A—testis—muscle cancer	0.00191	0.00657	CbGeAlD
Zonisamide—SCN1A—head—muscle cancer	0.00191	0.00656	CbGeAlD
Zonisamide—SCN2A—vagina—muscle cancer	0.00189	0.00652	CbGeAlD
Zonisamide—CA5B—tendon—muscle cancer	0.00185	0.00635	CbGeAlD
Zonisamide—SCN2B—Developmental Biology—MED12—muscle cancer	0.0018	0.00689	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—MED12—muscle cancer	0.0018	0.00689	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—MYOD1—muscle cancer	0.0018	0.00689	CbGpPWpGaD
Zonisamide—SCN3A—tendon—muscle cancer	0.00179	0.00617	CbGeAlD
Zonisamide—CA2—embryo—muscle cancer	0.00179	0.00615	CbGeAlD
Zonisamide—CA12—head—muscle cancer	0.00176	0.00607	CbGeAlD
Zonisamide—SCN2A—head—muscle cancer	0.00175	0.00602	CbGeAlD
Zonisamide—SCN3A—bone marrow—muscle cancer	0.00174	0.00598	CbGeAlD
Zonisamide—AOX1—tendon—muscle cancer	0.00172	0.00591	CbGeAlD
Zonisamide—CA5B—vagina—muscle cancer	0.00171	0.00589	CbGeAlD
Zonisamide—MAOB—renal system—muscle cancer	0.0017	0.00583	CbGeAlD
Zonisamide—CACNA1G—Developmental Biology—MYF5—muscle cancer	0.00168	0.00641	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—MYOD1—muscle cancer	0.00168	0.00641	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MYF6—muscle cancer	0.00168	0.00641	CbGpPWpGaD
Zonisamide—CA13—Metabolism—FH—muscle cancer	0.00167	0.0064	CbGpPWpGaD
Zonisamide—SCN3A—vagina—muscle cancer	0.00167	0.00573	CbGeAlD
Zonisamide—SCN5A—vagina—muscle cancer	0.00166	0.00571	CbGeAlD
Zonisamide—SCN4B—Developmental Biology—MED12—muscle cancer	0.00165	0.0063	CbGpPWpGaD
Zonisamide—CA4—renal system—muscle cancer	0.00163	0.00562	CbGeAlD
Zonisamide—CACNA1H—Developmental Biology—MYF5—muscle cancer	0.00162	0.0062	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MYF6—muscle cancer	0.00162	0.0062	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MYF5—muscle cancer	0.00159	0.00609	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MYF6—muscle cancer	0.00159	0.00609	CbGpPWpGaD
Zonisamide—AOX1—vagina—muscle cancer	0.00159	0.00548	CbGeAlD
Zonisamide—CA5B—head—muscle cancer	0.00158	0.00544	CbGeAlD
Zonisamide—CA1—bone marrow—muscle cancer	0.00158	0.00543	CbGeAlD
Zonisamide—SCN3A—head—muscle cancer	0.00154	0.00529	CbGeAlD
Zonisamide—SCN5A—head—muscle cancer	0.00153	0.00528	CbGeAlD
Zonisamide—SCN3B—Developmental Biology—MED12—muscle cancer	0.00153	0.00586	CbGpPWpGaD
Zonisamide—CA5B—testis—muscle cancer	0.00153	0.00526	CbGeAlD
Zonisamide—SCN3A—Developmental Biology—MYF6—muscle cancer	0.00152	0.00583	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MYF5—muscle cancer	0.00152	0.00583	CbGpPWpGaD
Zonisamide—MAOB—cardiac atrium—muscle cancer	0.00152	0.00522	CbGeAlD
Zonisamide—SCN3A—testis—muscle cancer	0.00149	0.00511	CbGeAlD
Zonisamide—SCN2A—Developmental Biology—MYF6—muscle cancer	0.00146	0.0056	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MYF5—muscle cancer	0.00146	0.0056	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MYF5—muscle cancer	0.00146	0.0056	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MYF6—muscle cancer	0.00146	0.0056	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MYOG—muscle cancer	0.00146	0.0056	CbGpPWpGaD
Zonisamide—CA4—cardiac atrium—muscle cancer	0.00146	0.00503	CbGeAlD
Zonisamide—MAOA—renal system—muscle cancer	0.00145	0.00498	CbGeAlD
Zonisamide—AOX1—testis—muscle cancer	0.00142	0.00489	CbGeAlD
Zonisamide—SCN1A—Developmental Biology—MYF5—muscle cancer	0.00141	0.0054	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MYF6—muscle cancer	0.00141	0.0054	CbGpPWpGaD
Zonisamide—CA2—smooth muscle tissue—muscle cancer	0.00141	0.00484	CbGeAlD
Zonisamide—CA1—head—muscle cancer	0.0014	0.00481	CbGeAlD
Zonisamide—SCN11A—Developmental Biology—MYOG—muscle cancer	0.00139	0.00531	CbGpPWpGaD
Zonisamide—SCN3B—Direct p53 effectors—MDM2—muscle cancer	0.00138	0.00529	CbGpPWpGaD
Zonisamide—MAOA—Melatonin metabolism and effects—FOXO1—muscle cancer	0.00137	0.00524	CbGpPWpGaD
Zonisamide—CA2—renal system—muscle cancer	0.00135	0.00466	CbGeAlD
Zonisamide—MAOB—tendon—muscle cancer	0.00132	0.00455	CbGeAlD
Zonisamide—MAOA—cardiac atrium—muscle cancer	0.0013	0.00446	CbGeAlD
Zonisamide—SCN5A—Cardiac Progenitor Differentiation—IGF2—muscle cancer	0.00129	0.00492	CbGpPWpGaD
Zonisamide—CA4—tendon—muscle cancer	0.00127	0.00438	CbGeAlD
Zonisamide—CA4—bone marrow—muscle cancer	0.00123	0.00425	CbGeAlD
Zonisamide—MAOB—vagina—muscle cancer	0.00123	0.00422	CbGeAlD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—TP73—muscle cancer	0.00122	0.00466	CbGpPWpGaD
Zonisamide—CA2—cardiac atrium—muscle cancer	0.00121	0.00417	CbGeAlD
Zonisamide—CA9—Cellular response to hypoxia—VEGFA—muscle cancer	0.00119	0.00455	CbGpPWpGaD
Zonisamide—MAOB—head—muscle cancer	0.00113	0.0039	CbGeAlD
Zonisamide—MAOA—tendon—muscle cancer	0.00113	0.00388	CbGeAlD
Zonisamide—MAOB—testis—muscle cancer	0.0011	0.00377	CbGeAlD
Zonisamide—CA4—head—muscle cancer	0.00109	0.00376	CbGeAlD
Zonisamide—CACNA1G—Developmental Biology—MYOG—muscle cancer	0.00108	0.00413	CbGpPWpGaD
Zonisamide—AOX1—Tryptophan metabolism—MDM2—muscle cancer	0.00107	0.0041	CbGpPWpGaD
Zonisamide—CYP2C19—vagina—muscle cancer	0.00107	0.00368	CbGeAlD
Zonisamide—CA2—tendon—muscle cancer	0.00106	0.00364	CbGeAlD
Zonisamide—CA4—testis—muscle cancer	0.00106	0.00363	CbGeAlD
Zonisamide—MAOA—vagina—muscle cancer	0.00105	0.0036	CbGeAlD
Zonisamide—CACNA1H—Developmental Biology—MYOG—muscle cancer	0.00105	0.004	CbGpPWpGaD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.00104	0.00396	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MYOG—muscle cancer	0.00103	0.00393	CbGpPWpGaD
Zonisamide—CA2—bone marrow—muscle cancer	0.00102	0.00352	CbGeAlD
Zonisamide—SCN5A—Developmental Biology—MYF6—muscle cancer	0.000993	0.0038	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MYF5—muscle cancer	0.000993	0.0038	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—FOXO1—muscle cancer	0.00099	0.00378	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—FOXO1—muscle cancer	0.00099	0.00378	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MYOG—muscle cancer	0.000983	0.00376	CbGpPWpGaD
Zonisamide—CA2—vagina—muscle cancer	0.000981	0.00337	CbGeAlD
Zonisamide—MAOA—head—muscle cancer	0.000968	0.00333	CbGeAlD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000964	0.00368	CbGpPWpGaD
Zonisamide—CA13—Metabolism—MED12—muscle cancer	0.000946	0.00362	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MYOG—muscle cancer	0.000944	0.00361	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MYOG—muscle cancer	0.000944	0.00361	CbGpPWpGaD
Zonisamide—MAOA—testis—muscle cancer	0.000935	0.00322	CbGeAlD
Zonisamide—SCN1A—Developmental Biology—MYOG—muscle cancer	0.00091	0.00348	CbGpPWpGaD
Zonisamide—MAOB—Tryptophan metabolism—MDM2—muscle cancer	0.000907	0.00347	CbGpPWpGaD
Zonisamide—CA2—head—muscle cancer	0.000906	0.00312	CbGeAlD
Zonisamide—SCN4B—Developmental Biology—FOXO1—muscle cancer	0.000905	0.00346	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MYOD1—muscle cancer	0.000905	0.00346	CbGpPWpGaD
Zonisamide—SCN5A—Cardiac Progenitor Differentiation—KIT—muscle cancer	0.000902	0.00345	CbGpPWpGaD
Zonisamide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	0.000889	0.0034	CbGpPWpGaD
Zonisamide—CA3—Metabolism—FH—muscle cancer	0.00088	0.00336	CbGpPWpGaD
Zonisamide—CA2—testis—muscle cancer	0.000875	0.00301	CbGeAlD
Zonisamide—CYP3A4—renal system—muscle cancer	0.000874	0.003	CbGeAlD
Zonisamide—MAOA—SIDS Susceptibility Pathways—TP73—muscle cancer	0.000872	0.00333	CbGpPWpGaD
Zonisamide—CA13—Metabolism—ENO2—muscle cancer	0.000863	0.0033	CbGpPWpGaD
Zonisamide—CA1—C-MYB transcription factor network—KIT—muscle cancer	0.000858	0.00328	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—MYOD1—muscle cancer	0.000858	0.00328	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—FOXO1—muscle cancer	0.000841	0.00322	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MED12—muscle cancer	0.000828	0.00316	CbGpPWpGaD
Zonisamide—SCN3B—Direct p53 effectors—TP53—muscle cancer	0.000794	0.00304	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—MED12—muscle cancer	0.000785	0.003	CbGpPWpGaD
Zonisamide—CA1—C-MYB transcription factor network—CDKN2A—muscle cancer	0.000697	0.00266	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MYOD1—muscle cancer	0.000667	0.00255	CbGpPWpGaD
Zonisamide—Vertigo—Etoposide—muscle cancer	0.000658	0.00176	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000656	0.00175	CcSEcCtD
Zonisamide—Leukopenia—Etoposide—muscle cancer	0.000656	0.00175	CcSEcCtD
Zonisamide—Body temperature increased—Dactinomycin—muscle cancer	0.000653	0.00175	CcSEcCtD
Zonisamide—Abdominal pain—Dactinomycin—muscle cancer	0.000653	0.00175	CcSEcCtD
Zonisamide—CA1—C-MYB transcription factor network—PTGS2—muscle cancer	0.000652	0.00249	CbGpPWpGaD
Zonisamide—CYP2C19—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000649	0.00248	CbGpPWpGaD
Zonisamide—Cardiac failure—Doxorubicin—muscle cancer	0.000647	0.00173	CcSEcCtD
Zonisamide—Hypoglycaemia—Doxorubicin—muscle cancer	0.000647	0.00173	CcSEcCtD
Zonisamide—CACNA1H—Developmental Biology—MYOD1—muscle cancer	0.000646	0.00247	CbGpPWpGaD
Zonisamide—Loss of consciousness—Etoposide—muscle cancer	0.000644	0.00172	CcSEcCtD
Zonisamide—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000644	0.00172	CcSEcCtD
Zonisamide—Decreased appetite—Vincristine—muscle cancer	0.000642	0.00172	CcSEcCtD
Zonisamide—SCN5A—Developmental Biology—MYOG—muscle cancer	0.00064	0.00245	CbGpPWpGaD
Zonisamide—Cough—Etoposide—muscle cancer	0.000639	0.00171	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Vincristine—muscle cancer	0.000637	0.0017	CcSEcCtD
Zonisamide—Fatigue—Vincristine—muscle cancer	0.000636	0.0017	CcSEcCtD
Zonisamide—Convulsion—Etoposide—muscle cancer	0.000635	0.0017	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—MYOD1—muscle cancer	0.000635	0.00243	CbGpPWpGaD
Zonisamide—Hyponatraemia—Doxorubicin—muscle cancer	0.000634	0.00169	CcSEcCtD
Zonisamide—Hypertension—Etoposide—muscle cancer	0.000633	0.00169	CcSEcCtD
Zonisamide—SCN1B—Axon guidance—VEGFA—muscle cancer	0.000632	0.00241	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—VEGFA—muscle cancer	0.000632	0.00241	CbGpPWpGaD
Zonisamide—Constipation—Vincristine—muscle cancer	0.000631	0.00169	CcSEcCtD
Zonisamide—Diplopia—Doxorubicin—muscle cancer	0.000631	0.00169	CcSEcCtD
Zonisamide—Osteoarthritis—Doxorubicin—muscle cancer	0.000631	0.00169	CcSEcCtD
Zonisamide—Chest pain—Etoposide—muscle cancer	0.000624	0.00167	CcSEcCtD
Zonisamide—Eosinophilia—Methotrexate—muscle cancer	0.000624	0.00167	CcSEcCtD
Zonisamide—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	0.000622	0.00238	CbGpPWpGaD
Zonisamide—Affect lability—Doxorubicin—muscle cancer	0.000621	0.00166	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00062	0.00166	CcSEcCtD
Zonisamide—Pancreatitis—Methotrexate—muscle cancer	0.000618	0.00165	CcSEcCtD
Zonisamide—Discomfort—Etoposide—muscle cancer	0.000616	0.00165	CcSEcCtD
Zonisamide—CACNA1G—Developmental Biology—MED12—muscle cancer	0.00061	0.00233	CbGpPWpGaD
Zonisamide—Face oedema—Doxorubicin—muscle cancer	0.000609	0.00163	CcSEcCtD
Zonisamide—Hypersensitivity—Dactinomycin—muscle cancer	0.000609	0.00163	CcSEcCtD
Zonisamide—SCN3A—Developmental Biology—MYOD1—muscle cancer	0.000607	0.00232	CbGpPWpGaD
Zonisamide—Gastrointestinal pain—Vincristine—muscle cancer	0.000604	0.00161	CcSEcCtD
Zonisamide—Confusional state—Etoposide—muscle cancer	0.000603	0.00161	CcSEcCtD
Zonisamide—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.0006	0.00229	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—HMGA1—muscle cancer	0.000598	0.00229	CbGpPWpGaD
Zonisamide—Pancytopenia—Methotrexate—muscle cancer	0.000598	0.0016	CcSEcCtD
Zonisamide—Mood swings—Doxorubicin—muscle cancer	0.000598	0.0016	CcSEcCtD
Zonisamide—Infection—Etoposide—muscle cancer	0.000594	0.00159	CcSEcCtD
Zonisamide—Ataxia—Doxorubicin—muscle cancer	0.000593	0.00159	CcSEcCtD
Zonisamide—Asthenia—Dactinomycin—muscle cancer	0.000593	0.00158	CcSEcCtD
Zonisamide—Blood creatinine increased—Doxorubicin—muscle cancer	0.000591	0.00158	CcSEcCtD
Zonisamide—CACNA1H—Developmental Biology—MED12—muscle cancer	0.000591	0.00226	CbGpPWpGaD
Zonisamide—Dysuria—Methotrexate—muscle cancer	0.000589	0.00157	CcSEcCtD
Zonisamide—Dehydration—Doxorubicin—muscle cancer	0.000587	0.00157	CcSEcCtD
Zonisamide—Thrombocytopenia—Etoposide—muscle cancer	0.000586	0.00157	CcSEcCtD
Zonisamide—Tachycardia—Etoposide—muscle cancer	0.000584	0.00156	CcSEcCtD
Zonisamide—Body temperature increased—Vincristine—muscle cancer	0.000584	0.00156	CcSEcCtD
Zonisamide—Abdominal pain—Vincristine—muscle cancer	0.000584	0.00156	CcSEcCtD
Zonisamide—SCN2A—Developmental Biology—MYOD1—muscle cancer	0.000583	0.00223	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MYOD1—muscle cancer	0.000583	0.00223	CbGpPWpGaD
Zonisamide—Liver function test abnormal—Doxorubicin—muscle cancer	0.000583	0.00156	CcSEcCtD
Zonisamide—Skin disorder—Etoposide—muscle cancer	0.000581	0.00155	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—MED12—muscle cancer	0.00058	0.00222	CbGpPWpGaD
Zonisamide—Erectile dysfunction—Methotrexate—muscle cancer	0.00058	0.00155	CcSEcCtD
Zonisamide—Dry skin—Doxorubicin—muscle cancer	0.000578	0.00155	CcSEcCtD
Zonisamide—Hyperhidrosis—Etoposide—muscle cancer	0.000578	0.00155	CcSEcCtD
Zonisamide—SCN4B—Axon guidance—VEGFA—muscle cancer	0.000578	0.00221	CbGpPWpGaD
Zonisamide—Hypokalaemia—Doxorubicin—muscle cancer	0.000574	0.00154	CcSEcCtD
Zonisamide—Anorexia—Etoposide—muscle cancer	0.00057	0.00152	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000568	0.00152	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000568	0.00152	CcSEcCtD
Zonisamide—CA14—Metabolism—FH—muscle cancer	0.000567	0.00217	CbGpPWpGaD
Zonisamide—Diarrhoea—Dactinomycin—muscle cancer	0.000565	0.00151	CcSEcCtD
Zonisamide—Pneumonia—Methotrexate—muscle cancer	0.000565	0.00151	CcSEcCtD
Zonisamide—SCN1A—Developmental Biology—MYOD1—muscle cancer	0.000562	0.00215	CbGpPWpGaD
Zonisamide—Depression—Methotrexate—muscle cancer	0.00056	0.0015	CcSEcCtD
Zonisamide—Hypotension—Etoposide—muscle cancer	0.000559	0.00149	CcSEcCtD
Zonisamide—Gastritis—Doxorubicin—muscle cancer	0.000558	0.00149	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000557	0.00149	CcSEcCtD
Zonisamide—Muscular weakness—Doxorubicin—muscle cancer	0.000557	0.00149	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000557	0.00149	CcSEcCtD
Zonisamide—SCN3A—Developmental Biology—MED12—muscle cancer	0.000555	0.00212	CbGpPWpGaD
Zonisamide—CA6—Metabolism—FH—muscle cancer	0.000552	0.00211	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—FH—muscle cancer	0.000552	0.00211	CbGpPWpGaD
Zonisamide—Renal failure—Methotrexate—muscle cancer	0.000552	0.00148	CcSEcCtD
Zonisamide—Stomatitis—Methotrexate—muscle cancer	0.000547	0.00146	CcSEcCtD
Zonisamide—CA9—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	0.000547	0.00209	CbGpPWpGaD
Zonisamide—Conjunctivitis—Methotrexate—muscle cancer	0.000546	0.00146	CcSEcCtD
Zonisamide—Influenza—Doxorubicin—muscle cancer	0.000545	0.00146	CcSEcCtD
Zonisamide—Dysphagia—Doxorubicin—muscle cancer	0.000545	0.00146	CcSEcCtD
Zonisamide—Hypersensitivity—Vincristine—muscle cancer	0.000544	0.00145	CcSEcCtD
Zonisamide—Eosinophilia—Doxorubicin—muscle cancer	0.00054	0.00144	CcSEcCtD
Zonisamide—Sweating—Methotrexate—muscle cancer	0.000538	0.00144	CcSEcCtD
Zonisamide—SCN3B—Axon guidance—VEGFA—muscle cancer	0.000537	0.00205	CbGpPWpGaD
Zonisamide—Paraesthesia—Etoposide—muscle cancer	0.000537	0.00144	CcSEcCtD
Zonisamide—Haematuria—Methotrexate—muscle cancer	0.000535	0.00143	CcSEcCtD
Zonisamide—Pancreatitis—Doxorubicin—muscle cancer	0.000535	0.00143	CcSEcCtD
Zonisamide—SCN2A—Developmental Biology—MED12—muscle cancer	0.000533	0.00204	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MED12—muscle cancer	0.000533	0.00204	CbGpPWpGaD
Zonisamide—Dyspnoea—Etoposide—muscle cancer	0.000533	0.00143	CcSEcCtD
Zonisamide—Somnolence—Etoposide—muscle cancer	0.000532	0.00142	CcSEcCtD
Zonisamide—Hepatobiliary disease—Methotrexate—muscle cancer	0.000531	0.00142	CcSEcCtD
Zonisamide—Asthenia—Vincristine—muscle cancer	0.00053	0.00142	CcSEcCtD
Zonisamide—Vomiting—Dactinomycin—muscle cancer	0.000525	0.0014	CcSEcCtD
Zonisamide—Agranulocytosis—Methotrexate—muscle cancer	0.000524	0.0014	CcSEcCtD
Zonisamide—Rash—Dactinomycin—muscle cancer	0.000521	0.00139	CcSEcCtD
Zonisamide—Decreased appetite—Etoposide—muscle cancer	0.00052	0.00139	CcSEcCtD
Zonisamide—Pancytopenia—Doxorubicin—muscle cancer	0.000518	0.00138	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Etoposide—muscle cancer	0.000516	0.00138	CcSEcCtD
Zonisamide—CA5B—Metabolism—FH—muscle cancer	0.000516	0.00197	CbGpPWpGaD
Zonisamide—CA7—Metabolism—FH—muscle cancer	0.000516	0.00197	CbGpPWpGaD
Zonisamide—Fatigue—Etoposide—muscle cancer	0.000516	0.00138	CcSEcCtD
Zonisamide—SCN1A—Developmental Biology—MED12—muscle cancer	0.000514	0.00197	CbGpPWpGaD
Zonisamide—Constipation—Etoposide—muscle cancer	0.000511	0.00137	CcSEcCtD
Zonisamide—Dysuria—Doxorubicin—muscle cancer	0.00051	0.00136	CcSEcCtD
Zonisamide—Diarrhoea—Vincristine—muscle cancer	0.000505	0.00135	CcSEcCtD
Zonisamide—Pollakiuria—Doxorubicin—muscle cancer	0.000504	0.00135	CcSEcCtD
Zonisamide—Pharyngitis—Methotrexate—muscle cancer	0.0005	0.00134	CcSEcCtD
Zonisamide—Urinary tract disorder—Methotrexate—muscle cancer	0.000498	0.00133	CcSEcCtD
Zonisamide—CA3—Metabolism—MED12—muscle cancer	0.000497	0.0019	CbGpPWpGaD
Zonisamide—Weight increased—Doxorubicin—muscle cancer	0.000496	0.00133	CcSEcCtD
Zonisamide—Urethral disorder—Methotrexate—muscle cancer	0.000494	0.00132	CcSEcCtD
Zonisamide—Weight decreased—Doxorubicin—muscle cancer	0.000493	0.00132	CcSEcCtD
Zonisamide—Feeling abnormal—Etoposide—muscle cancer	0.000493	0.00132	CcSEcCtD
Zonisamide—Nausea—Dactinomycin—muscle cancer	0.000491	0.00131	CcSEcCtD
Zonisamide—Pneumonia—Doxorubicin—muscle cancer	0.000489	0.00131	CcSEcCtD
Zonisamide—Gastrointestinal pain—Etoposide—muscle cancer	0.000489	0.00131	CcSEcCtD
Zonisamide—Dizziness—Vincristine—muscle cancer	0.000488	0.0013	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000482	0.00129	CcSEcCtD
Zonisamide—Renal failure—Doxorubicin—muscle cancer	0.000478	0.00128	CcSEcCtD
Zonisamide—CA12—Metabolism—FH—muscle cancer	0.000478	0.00183	CbGpPWpGaD
Zonisamide—Erythema multiforme—Methotrexate—muscle cancer	0.000477	0.00127	CcSEcCtD
Zonisamide—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000477	0.00127	CcSEcCtD
Zonisamide—Urticaria—Etoposide—muscle cancer	0.000475	0.00127	CcSEcCtD
Zonisamide—Stomatitis—Doxorubicin—muscle cancer	0.000474	0.00127	CcSEcCtD
Zonisamide—Body temperature increased—Etoposide—muscle cancer	0.000473	0.00126	CcSEcCtD
Zonisamide—Abdominal pain—Etoposide—muscle cancer	0.000473	0.00126	CcSEcCtD
Zonisamide—Urinary tract infection—Doxorubicin—muscle cancer	0.000473	0.00126	CcSEcCtD
Zonisamide—Conjunctivitis—Doxorubicin—muscle cancer	0.000473	0.00126	CcSEcCtD
Zonisamide—Eye disorder—Methotrexate—muscle cancer	0.000471	0.00126	CcSEcCtD
Zonisamide—Tinnitus—Methotrexate—muscle cancer	0.00047	0.00126	CcSEcCtD
Zonisamide—Vomiting—Vincristine—muscle cancer	0.000469	0.00125	CcSEcCtD
Zonisamide—Sweating—Doxorubicin—muscle cancer	0.000466	0.00125	CcSEcCtD
Zonisamide—Rash—Vincristine—muscle cancer	0.000465	0.00124	CcSEcCtD
Zonisamide—Dermatitis—Vincristine—muscle cancer	0.000465	0.00124	CcSEcCtD
Zonisamide—Haematuria—Doxorubicin—muscle cancer	0.000464	0.00124	CcSEcCtD
Zonisamide—Headache—Vincristine—muscle cancer	0.000462	0.00124	CcSEcCtD
Zonisamide—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00046	0.00123	CcSEcCtD
Zonisamide—Immune system disorder—Methotrexate—muscle cancer	0.000455	0.00122	CcSEcCtD
Zonisamide—Mediastinal disorder—Methotrexate—muscle cancer	0.000454	0.00121	CcSEcCtD
Zonisamide—CACNA1I—Developmental Biology—FOXO1—muscle cancer	0.000454	0.00174	CbGpPWpGaD
Zonisamide—Agranulocytosis—Doxorubicin—muscle cancer	0.000454	0.00121	CcSEcCtD
Zonisamide—CA3—Metabolism—ENO2—muscle cancer	0.000453	0.00173	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—VEGFA—muscle cancer	0.000451	0.00172	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—VEGFA—muscle cancer	0.000451	0.00172	CbGpPWpGaD
Zonisamide—Alopecia—Methotrexate—muscle cancer	0.000446	0.00119	CcSEcCtD
Zonisamide—Bradycardia—Doxorubicin—muscle cancer	0.000444	0.00119	CcSEcCtD
Zonisamide—Mental disorder—Methotrexate—muscle cancer	0.000442	0.00118	CcSEcCtD
Zonisamide—Hypersensitivity—Etoposide—muscle cancer	0.000441	0.00118	CcSEcCtD
Zonisamide—Malnutrition—Methotrexate—muscle cancer	0.000439	0.00117	CcSEcCtD
Zonisamide—Nausea—Vincristine—muscle cancer	0.000438	0.00117	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—muscle cancer	0.000438	0.00117	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—muscle cancer	0.000433	0.00116	CcSEcCtD
Zonisamide—Urinary tract disorder—Doxorubicin—muscle cancer	0.000431	0.00115	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—FOXO1—muscle cancer	0.000431	0.00165	CbGpPWpGaD
Zonisamide—Oedema peripheral—Doxorubicin—muscle cancer	0.00043	0.00115	CcSEcCtD
Zonisamide—Dysgeusia—Methotrexate—muscle cancer	0.00043	0.00115	CcSEcCtD
Zonisamide—Asthenia—Etoposide—muscle cancer	0.000429	0.00115	CcSEcCtD
Zonisamide—Connective tissue disorder—Doxorubicin—muscle cancer	0.000429	0.00115	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—muscle cancer	0.000428	0.00114	CcSEcCtD
Zonisamide—Pruritus—Etoposide—muscle cancer	0.000423	0.00113	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—muscle cancer	0.000413	0.0011	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—VEGFA—muscle cancer	0.000412	0.00158	CbGpPWpGaD
Zonisamide—Diarrhoea—Etoposide—muscle cancer	0.000409	0.00109	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—muscle cancer	0.000408	0.00109	CcSEcCtD
Zonisamide—Ill-defined disorder—Methotrexate—muscle cancer	0.000407	0.00109	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—muscle cancer	0.000407	0.00109	CcSEcCtD
Zonisamide—Anaemia—Methotrexate—muscle cancer	0.000406	0.00108	CcSEcCtD
Zonisamide—Malaise—Methotrexate—muscle cancer	0.000396	0.00106	CcSEcCtD
Zonisamide—Dizziness—Etoposide—muscle cancer	0.000395	0.00106	CcSEcCtD
Zonisamide—SCN5A—Developmental Biology—MYOD1—muscle cancer	0.000395	0.00151	CbGpPWpGaD
Zonisamide—Immune system disorder—Doxorubicin—muscle cancer	0.000394	0.00105	CcSEcCtD
Zonisamide—Vertigo—Methotrexate—muscle cancer	0.000394	0.00105	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—muscle cancer	0.000393	0.00105	CcSEcCtD
Zonisamide—Leukopenia—Methotrexate—muscle cancer	0.000393	0.00105	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—muscle cancer	0.000386	0.00103	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—VEGFA—muscle cancer	0.000383	0.00147	CbGpPWpGaD
Zonisamide—Cough—Methotrexate—muscle cancer	0.000383	0.00102	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—muscle cancer	0.000382	0.00102	CcSEcCtD
Zonisamide—CA4—Metabolism—FH—muscle cancer	0.000381	0.00146	CbGpPWpGaD
Zonisamide—Convulsion—Methotrexate—muscle cancer	0.00038	0.00102	CcSEcCtD
Zonisamide—Vomiting—Etoposide—muscle cancer	0.00038	0.00102	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—muscle cancer	0.00038	0.00102	CcSEcCtD
Zonisamide—Rash—Etoposide—muscle cancer	0.000377	0.00101	CcSEcCtD
Zonisamide—Dermatitis—Etoposide—muscle cancer	0.000377	0.00101	CcSEcCtD
Zonisamide—Headache—Etoposide—muscle cancer	0.000375	0.001	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—muscle cancer	0.000374	0.001	CcSEcCtD
Zonisamide—Arthralgia—Methotrexate—muscle cancer	0.000374	0.000999	CcSEcCtD
Zonisamide—Chest pain—Methotrexate—muscle cancer	0.000374	0.000999	CcSEcCtD
Zonisamide—Myalgia—Methotrexate—muscle cancer	0.000374	0.000999	CcSEcCtD
Zonisamide—Tension—Doxorubicin—muscle cancer	0.000373	0.000997	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—muscle cancer	0.000372	0.000995	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000371	0.000992	CcSEcCtD
Zonisamide—Discomfort—Methotrexate—muscle cancer	0.000369	0.000987	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—muscle cancer	0.000369	0.000987	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—muscle cancer	0.000365	0.000977	CcSEcCtD
Zonisamide—CA2—Metabolism—FH—muscle cancer	0.000365	0.0014	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MED12—muscle cancer	0.000362	0.00138	CbGpPWpGaD
Zonisamide—Confusional state—Methotrexate—muscle cancer	0.000361	0.000966	CcSEcCtD
Zonisamide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000361	0.00138	CbGpPWpGaD
Zonisamide—Infection—Methotrexate—muscle cancer	0.000356	0.000951	CcSEcCtD
Zonisamide—Nausea—Etoposide—muscle cancer	0.000355	0.00095	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—muscle cancer	0.000353	0.000943	CcSEcCtD
Zonisamide—Nervous system disorder—Methotrexate—muscle cancer	0.000351	0.000939	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—muscle cancer	0.000351	0.000939	CcSEcCtD
Zonisamide—Thrombocytopenia—Methotrexate—muscle cancer	0.000351	0.000938	CcSEcCtD
Zonisamide—CA1—Metabolism—FH—muscle cancer	0.00035	0.00134	CbGpPWpGaD
Zonisamide—Agitation—Doxorubicin—muscle cancer	0.000349	0.000934	CcSEcCtD
Zonisamide—Skin disorder—Methotrexate—muscle cancer	0.000348	0.00093	CcSEcCtD
Zonisamide—Hyperhidrosis—Methotrexate—muscle cancer	0.000346	0.000926	CcSEcCtD
Zonisamide—AOX1—Metabolism—FH—muscle cancer	0.000343	0.00131	CbGpPWpGaD
Zonisamide—Malaise—Doxorubicin—muscle cancer	0.000343	0.000916	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—muscle cancer	0.000341	0.000913	CcSEcCtD
Zonisamide—Anorexia—Methotrexate—muscle cancer	0.000341	0.000913	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—muscle cancer	0.000341	0.000911	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—muscle cancer	0.00034	0.000909	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—muscle cancer	0.000336	0.000898	CcSEcCtD
Zonisamide—CACNA1G—Developmental Biology—FOXO1—muscle cancer	0.000335	0.00128	CbGpPWpGaD
Zonisamide—Hypotension—Methotrexate—muscle cancer	0.000335	0.000895	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—muscle cancer	0.000334	0.000893	CcSEcCtD
Zonisamide—Cough—Doxorubicin—muscle cancer	0.000332	0.000887	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—muscle cancer	0.000329	0.00088	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—muscle cancer	0.000328	0.000877	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000326	0.000872	CcSEcCtD
Zonisamide—CACNA1H—Developmental Biology—FOXO1—muscle cancer	0.000324	0.00124	CbGpPWpGaD
Zonisamide—Insomnia—Methotrexate—muscle cancer	0.000324	0.000866	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—muscle cancer	0.000324	0.000865	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—muscle cancer	0.000324	0.000865	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—muscle cancer	0.000324	0.000865	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—muscle cancer	0.000322	0.000862	CcSEcCtD
Zonisamide—Paraesthesia—Methotrexate—muscle cancer	0.000322	0.00086	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000321	0.000859	CcSEcCtD
Zonisamide—CA14—Metabolism—MED12—muscle cancer	0.00032	0.00122	CbGpPWpGaD
Zonisamide—Discomfort—Doxorubicin—muscle cancer	0.00032	0.000855	CcSEcCtD
Zonisamide—Dyspnoea—Methotrexate—muscle cancer	0.000319	0.000854	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—FOXO1—muscle cancer	0.000319	0.00122	CbGpPWpGaD
Zonisamide—Somnolence—Methotrexate—muscle cancer	0.000318	0.000851	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—muscle cancer	0.000316	0.000846	CcSEcCtD
Zonisamide—Dyspepsia—Methotrexate—muscle cancer	0.000315	0.000843	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—muscle cancer	0.000313	0.000836	CcSEcCtD
Zonisamide—CA5A—Metabolism—MED12—muscle cancer	0.000312	0.00119	CbGpPWpGaD
Zonisamide—CA6—Metabolism—MED12—muscle cancer	0.000312	0.00119	CbGpPWpGaD
Zonisamide—Decreased appetite—Methotrexate—muscle cancer	0.000311	0.000832	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—muscle cancer	0.00031	0.000829	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000309	0.000827	CcSEcCtD
Zonisamide—Fatigue—Methotrexate—muscle cancer	0.000309	0.000826	CcSEcCtD
Zonisamide—Infection—Doxorubicin—muscle cancer	0.000308	0.000824	CcSEcCtD
Zonisamide—CA9—Metabolism—FH—muscle cancer	0.000308	0.00118	CbGpPWpGaD
Zonisamide—Shock—Doxorubicin—muscle cancer	0.000305	0.000816	CcSEcCtD
Zonisamide—SCN3A—Developmental Biology—FOXO1—muscle cancer	0.000305	0.00116	CbGpPWpGaD
Zonisamide—Nervous system disorder—Doxorubicin—muscle cancer	0.000304	0.000813	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—muscle cancer	0.000304	0.000812	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—muscle cancer	0.000303	0.000809	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—muscle cancer	0.000301	0.000805	CcSEcCtD
Zonisamide—CA13—Metabolism—PTGS2—muscle cancer	0.0003	0.00115	CbGpPWpGaD
Zonisamide—Hyperhidrosis—Doxorubicin—muscle cancer	0.0003	0.000802	CcSEcCtD
Zonisamide—Anorexia—Doxorubicin—muscle cancer	0.000296	0.00079	CcSEcCtD
Zonisamide—Feeling abnormal—Methotrexate—muscle cancer	0.000295	0.000789	CcSEcCtD
Zonisamide—Gastrointestinal pain—Methotrexate—muscle cancer	0.000293	0.000783	CcSEcCtD
Zonisamide—SCN4A—Developmental Biology—FOXO1—muscle cancer	0.000293	0.00112	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—FOXO1—muscle cancer	0.000293	0.00112	CbGpPWpGaD
Zonisamide—CA14—Metabolism—ENO2—muscle cancer	0.000292	0.00112	CbGpPWpGaD
Zonisamide—CA7—Metabolism—MED12—muscle cancer	0.000291	0.00111	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—MED12—muscle cancer	0.000291	0.00111	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—FH—muscle cancer	0.00029	0.00111	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—VEGFA—muscle cancer	0.00029	0.00111	CbGpPWpGaD
Zonisamide—Hypotension—Doxorubicin—muscle cancer	0.00029	0.000775	CcSEcCtD
Zonisamide—Urticaria—Methotrexate—muscle cancer	0.000285	0.000761	CcSEcCtD
Zonisamide—CA5A—Metabolism—ENO2—muscle cancer	0.000285	0.00109	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ENO2—muscle cancer	0.000285	0.00109	CbGpPWpGaD
Zonisamide—Abdominal pain—Methotrexate—muscle cancer	0.000283	0.000757	CcSEcCtD
Zonisamide—Body temperature increased—Methotrexate—muscle cancer	0.000283	0.000757	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000283	0.000755	CcSEcCtD
Zonisamide—SCN1A—Developmental Biology—FOXO1—muscle cancer	0.000282	0.00108	CbGpPWpGaD
Zonisamide—Insomnia—Doxorubicin—muscle cancer	0.000281	0.00075	CcSEcCtD
Zonisamide—Paraesthesia—Doxorubicin—muscle cancer	0.000279	0.000745	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—muscle cancer	0.000277	0.000739	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—muscle cancer	0.000276	0.000737	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—VEGFA—muscle cancer	0.000275	0.00105	CbGpPWpGaD
Zonisamide—Dyspepsia—Doxorubicin—muscle cancer	0.000273	0.00073	CcSEcCtD
Zonisamide—CA12—Metabolism—MED12—muscle cancer	0.00027	0.00103	CbGpPWpGaD
Zonisamide—Decreased appetite—Doxorubicin—muscle cancer	0.00027	0.000721	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000268	0.000716	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—muscle cancer	0.000267	0.000715	CcSEcCtD
Zonisamide—CA7—Metabolism—ENO2—muscle cancer	0.000266	0.00102	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ENO2—muscle cancer	0.000266	0.00102	CbGpPWpGaD
Zonisamide—Constipation—Doxorubicin—muscle cancer	0.000265	0.000709	CcSEcCtD
Zonisamide—Hypersensitivity—Methotrexate—muscle cancer	0.000264	0.000705	CcSEcCtD
Zonisamide—Asthenia—Methotrexate—muscle cancer	0.000257	0.000687	CcSEcCtD
Zonisamide—Feeling abnormal—Doxorubicin—muscle cancer	0.000256	0.000683	CcSEcCtD
Zonisamide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000254	0.000678	CcSEcCtD
Zonisamide—Pruritus—Methotrexate—muscle cancer	0.000253	0.000677	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—muscle cancer	0.000246	0.000659	CcSEcCtD
Zonisamide—CA12—Metabolism—ENO2—muscle cancer	0.000246	0.000941	CbGpPWpGaD
Zonisamide—Body temperature increased—Doxorubicin—muscle cancer	0.000245	0.000655	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—muscle cancer	0.000245	0.000655	CcSEcCtD
Zonisamide—CA9—Cellular responses to stress—CDKN2A—muscle cancer	0.000245	0.000937	CbGpPWpGaD
Zonisamide—Diarrhoea—Methotrexate—muscle cancer	0.000245	0.000655	CcSEcCtD
Zonisamide—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000243	0.000928	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—MDM2—muscle cancer	0.000238	0.000909	CbGpPWpGaD
Zonisamide—Dizziness—Methotrexate—muscle cancer	0.000237	0.000633	CcSEcCtD
Zonisamide—Hypersensitivity—Doxorubicin—muscle cancer	0.000229	0.000611	CcSEcCtD
Zonisamide—Vomiting—Methotrexate—muscle cancer	0.000228	0.000609	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000227	0.000869	CbGpPWpGaD
Zonisamide—Rash—Methotrexate—muscle cancer	0.000226	0.000604	CcSEcCtD
Zonisamide—Dermatitis—Methotrexate—muscle cancer	0.000226	0.000603	CcSEcCtD
Zonisamide—Headache—Methotrexate—muscle cancer	0.000224	0.0006	CcSEcCtD
Zonisamide—Asthenia—Doxorubicin—muscle cancer	0.000223	0.000595	CcSEcCtD
Zonisamide—Pruritus—Doxorubicin—muscle cancer	0.000219	0.000587	CcSEcCtD
Zonisamide—CA4—Metabolism—MED12—muscle cancer	0.000215	0.000823	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—VEGFA—muscle cancer	0.000214	0.000817	CbGpPWpGaD
Zonisamide—Nausea—Methotrexate—muscle cancer	0.000213	0.000569	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—muscle cancer	0.000212	0.000567	CcSEcCtD
Zonisamide—AOX1—Disease—ENO2—muscle cancer	0.000211	0.000807	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—VEGFA—muscle cancer	0.000207	0.000792	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—VEGFA—muscle cancer	0.000207	0.000791	CbGpPWpGaD
Zonisamide—CA2—Metabolism—MED12—muscle cancer	0.000206	0.000789	CbGpPWpGaD
Zonisamide—Dizziness—Doxorubicin—muscle cancer	0.000205	0.000548	CcSEcCtD
Zonisamide—SCN9A—Axon guidance—VEGFA—muscle cancer	0.000203	0.000778	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—FOXO1—muscle cancer	0.000198	0.000759	CbGpPWpGaD
Zonisamide—CA1—Metabolism—MED12—muscle cancer	0.000198	0.000756	CbGpPWpGaD
Zonisamide—Vomiting—Doxorubicin—muscle cancer	0.000197	0.000527	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—VEGFA—muscle cancer	0.000196	0.00075	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ENO2—muscle cancer	0.000196	0.00075	CbGpPWpGaD
Zonisamide—Rash—Doxorubicin—muscle cancer	0.000196	0.000523	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—muscle cancer	0.000195	0.000522	CcSEcCtD
Zonisamide—SCN3A—Axon guidance—VEGFA—muscle cancer	0.000195	0.000744	CbGpPWpGaD
Zonisamide—Headache—Doxorubicin—muscle cancer	0.000194	0.000519	CcSEcCtD
Zonisamide—AOX1—Metabolism—MED12—muscle cancer	0.000194	0.000742	CbGpPWpGaD
Zonisamide—AOX1—Disease—HMGA1—muscle cancer	0.000192	0.000734	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ENO2—muscle cancer	0.000188	0.000719	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—VEGFA—muscle cancer	0.000187	0.000715	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—VEGFA—muscle cancer	0.000187	0.000715	CbGpPWpGaD
Zonisamide—Nausea—Doxorubicin—muscle cancer	0.000184	0.000492	CcSEcCtD
Zonisamide—MAOA—Metabolism—FH—muscle cancer	0.000182	0.000696	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—VEGFA—muscle cancer	0.000181	0.00069	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ENO2—muscle cancer	0.00018	0.000689	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—VEGFA—muscle cancer	0.00018	0.000689	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ENO2—muscle cancer	0.000177	0.000676	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000176	0.000671	CbGpPWpGaD
Zonisamide—CA9—Metabolism—MED12—muscle cancer	0.000174	0.000665	CbGpPWpGaD
Zonisamide—AOX1—Disease—FOXO4—muscle cancer	0.000172	0.000658	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—MED12—muscle cancer	0.000164	0.000627	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000163	0.000622	CbGpPWpGaD
Zonisamide—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	0.000162	0.000619	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ENO2—muscle cancer	0.000159	0.000606	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTGS2—muscle cancer	0.000158	0.000603	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—VEGFA—muscle cancer	0.000153	0.000583	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ENO2—muscle cancer	0.000149	0.000571	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—VEGFA—muscle cancer	0.000148	0.000565	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—VEGFA—muscle cancer	0.000145	0.000555	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VEGFA—muscle cancer	0.000139	0.000531	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—muscle cancer	0.000136	0.000521	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—MDM2—muscle cancer	0.000135	0.000514	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VEGFA—muscle cancer	0.000133	0.00051	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VEGFA—muscle cancer	0.000133	0.00051	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VEGFA—muscle cancer	0.000129	0.000492	CbGpPWpGaD
Zonisamide—AOX1—Disease—FOXO1—muscle cancer	0.000127	0.000486	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VEGFA—muscle cancer	0.000127	0.000484	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000109	0.000418	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MED12—muscle cancer	0.000103	0.000393	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—muscle cancer	0.000102	0.000389	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—muscle cancer	9.91e-05	0.000379	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—muscle cancer	9.91e-05	0.000379	CbGpPWpGaD
Zonisamide—AOX1—Disease—KIT—muscle cancer	9.69e-05	0.00037	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ENO2—muscle cancer	9.38e-05	0.000358	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—muscle cancer	9.25e-05	0.000354	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—muscle cancer	9.25e-05	0.000354	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—muscle cancer	9.04e-05	0.000346	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—FH—muscle cancer	8.62e-05	0.000329	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—muscle cancer	8.57e-05	0.000328	CbGpPWpGaD
Zonisamide—AOX1—Disease—MDM2—muscle cancer	7.63e-05	0.000292	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—muscle cancer	7.36e-05	0.000281	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—muscle cancer	6.84e-05	0.000261	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—muscle cancer	6.55e-05	0.00025	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—muscle cancer	6.28e-05	0.00024	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—muscle cancer	6.16e-05	0.000235	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—muscle cancer	5.52e-05	0.000211	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—muscle cancer	5.21e-05	0.000199	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—FH—muscle cancer	5.18e-05	0.000198	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MED12—muscle cancer	4.87e-05	0.000186	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ENO2—muscle cancer	4.44e-05	0.00017	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.47e-05	0.000133	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—muscle cancer	3.27e-05	0.000125	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MED12—muscle cancer	2.93e-05	0.000112	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENO2—muscle cancer	2.67e-05	0.000102	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—muscle cancer	1.55e-05	5.91e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—muscle cancer	9.3e-06	3.55e-05	CbGpPWpGaD
